Overall KRYS gets a fundamental rating of 6 out of 10. We evaluated KRYS against 525 industry peers in the Biotechnology industry. While KRYS has a great health rating, its profitability is only average at the moment. KRYS has a decent growth rate and is not valued too expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year KRYS was profitable.
In the past year KRYS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KRYS reported negative net income in multiple years.
In the past 5 years KRYS reported 4 times negative operating cash flow.

1.2 Ratios

The Return On Assets of KRYS (16.04%) is better than 95.81% of its industry peers.
With an excellent Return On Equity value of 17.48%, KRYS belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
KRYS's Return On Invested Capital of 12.28% is amongst the best of the industry. KRYS outperforms 95.24% of its industry peers.

		Industry Rank	Sector Rank
ROA	16.04%
ROE	17.48%
ROIC	12.28%

ROA(3y)-5.09%

ROA(5y)-7.35%

ROE(3y)-5.33%

ROE(5y)-7.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

KRYS has a better Profit Margin (53.30%) than 98.48% of its industry peers.
KRYS's Operating Margin of 42.40% is amongst the best of the industry. KRYS outperforms 99.24% of its industry peers.
With an excellent Gross Margin value of 94.26%, KRYS belongs to the best of the industry, outperforming 94.67% of the companies in the same industry.

		Industry Rank	Sector Rank
OM	42.4%
PM (TTM)	53.3%
GM	94.26%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KRYS is creating some value.
KRYS has more shares outstanding than it did 1 year ago.
KRYS has more shares outstanding than it did 5 years ago.
There is no outstanding debt for KRYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 48.95 indicates that KRYS is not in any danger for bankruptcy at the moment.
The Altman-Z score of KRYS (48.95) is better than 96.00% of its industry peers.
KRYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	48.95

ROIC/WACC1.39

WACC8.86%

2.3 Liquidity

KRYS has a Current Ratio of 10.14. This indicates that KRYS is financially healthy and has no problem in meeting its short term obligations.
KRYS's Current ratio of 10.14 is amongst the best of the industry. KRYS outperforms 81.14% of its industry peers.
A Quick Ratio of 9.73 indicates that KRYS has no problem at all paying its short term obligations.
KRYS has a better Quick ratio (9.73) than 80.38% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	10.14
Quick Ratio	9.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 276.84% over the past year.
KRYS shows a strong growth in Revenue. In the last year, the Revenue has grown by 54.51%.

EPS 1Y (TTM)276.84%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%192.31%

Revenue 1Y (TTM)54.51%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%16.65%

3.2 Future

KRYS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.10% yearly.
KRYS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.67% yearly.

EPS Next Y114.44%

EPS Next 2Y64.64%

EPS Next 3Y46.4%

EPS Next 5Y58.1%

Revenue Next Year34.01%

Revenue Next 2Y38.02%

Revenue Next 3Y36.66%

Revenue Next 5Y31.67%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 41.58, which means the current valuation is very expensive for KRYS.
Based on the Price/Earnings ratio, KRYS is valued cheaply inside the industry as 91.24% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.87, KRYS is valued a bit more expensive.
With a Price/Forward Earnings ratio of 34.22, KRYS can be considered very expensive at the moment.
KRYS's Price/Forward Earnings ratio is rather cheap when compared to the industry. KRYS is cheaper than 91.62% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 25.96, KRYS is valued a bit more expensive.

		Industry Rank	Sector Rank
PE	41.58
Fwd PE	34.22

4.2 Price Multiples

91.62% of the companies in the same industry are more expensive than KRYS, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KRYS indicates a rather cheap valuation: KRYS is cheaper than 92.76% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	48.58
EV/EBITDA	42.98

4.3 Compensation for Growth

KRYS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KRYS may justify a higher PE ratio.
KRYS's earnings are expected to grow with 46.40% in the coming years. This may justify a more expensive valuation.